Derek M Dykxhoorn

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Biomed Eng 8:377-402. 2006
  2. ncbi MicroRNAs in viral replication and pathogenesis
    Derek M Dykxhoorn
    The CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
    DNA Cell Biol 26:239-49. 2007
  3. ncbi The silent revolution: RNA interference as basic biology, research tool, and therapeutic
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Med 56:401-23. 2005
  4. ncbi miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells
    Ashish Lal
    Immune Disease Institute and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
    Nat Struct Mol Biol 16:492-8. 2009
  5. ncbi Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages
    Erwei Song
    Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Virol 77:7174-81. 2003
  6. ncbi Knocking down disease with siRNAs
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
    Cell 126:231-5. 2006
  7. ncbi Identification of host proteins required for HIV infection through a functional genomic screen
    Abraham L Brass
    Department of Genetics, Center for Genetics and Genomics, Brigham and Women s Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA
    Science 319:921-6. 2008
  8. ncbi Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV
    Sang Kyung Lee
    The CBR Institute for Biomedical Research, 800 Huntington Ave, Boston, MA 02115, USA
    Blood 106:818-26. 2005
  9. ncbi Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
    Erwei Song
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
    Nat Biotechnol 23:709-17. 2005
  10. ncbi miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements
    Ashish Lal
    Immune Disease Institute, Children s Hospital Boston, Department of Pediatrics, Harvard Medical School, MA 02115, USA
    Mol Cell 35:610-25. 2009

Collaborators

Detail Information

Publications21

  1. ncbi Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Biomed Eng 8:377-402. 2006
    ..Pilot siRNA clinical studies began just three years after the discovery that RNAi works in mammalian cells. This review discusses recent progress and obstacles to using siRNAs as small molecule drugs...
  2. ncbi MicroRNAs in viral replication and pathogenesis
    Derek M Dykxhoorn
    The CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA
    DNA Cell Biol 26:239-49. 2007
    ....
  3. ncbi The silent revolution: RNA interference as basic biology, research tool, and therapeutic
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Med 56:401-23. 2005
    ..RNAi may provide an important new therapeutic modality for treating infection, cancer, neurodegenerative disease, and other illnesses, although in vivo delivery of small interfering RNAs into cells remains a significant obstacle...
  4. ncbi miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells
    Ashish Lal
    Immune Disease Institute and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
    Nat Struct Mol Biol 16:492-8. 2009
    ..Therefore, miR-24 upregulation in postreplicative cells reduces H2AX and makes them vulnerable to DNA damage...
  5. ncbi Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages
    Erwei Song
    Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Virol 77:7174-81. 2003
    ..Under these circumstances, long-term suppression of HIV replication could be achieved with p24 siRNA. Thus, siRNAs can induce potent and long-lasting HIV inhibition in nondividing cells such as macrophages...
  6. ncbi Knocking down disease with siRNAs
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
    Cell 126:231-5. 2006
    ..This Essay will examine the opportunities for harnessing RNA interference (RNAi) for therapy, as well as the obstacles and possible ways to circumvent them...
  7. ncbi Identification of host proteins required for HIV infection through a functional genomic screen
    Abraham L Brass
    Department of Genetics, Center for Genetics and Genomics, Brigham and Women s Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA
    Science 319:921-6. 2008
    ..This effort illustrates the power with which RNA interference and forward genetics can be used to expose the dependencies of human pathogens such as HIV, and in so doing identify potential targets for therapy...
  8. ncbi Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV
    Sang Kyung Lee
    The CBR Institute for Biomedical Research, 800 Huntington Ave, Boston, MA 02115, USA
    Blood 106:818-26. 2005
    ..Thus, although 1 or 2 mutations at peripheral sites are tolerated, mutations in the central target cleavage region abolish RNAi activity...
  9. ncbi Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
    Erwei Song
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
    Nat Biotechnol 23:709-17. 2005
    ..Furthermore, an ErbB2 single-chain antibody fused with protamine delivered siRNAs specifically into ErbB2-expressing cancer cells. This study demonstrates the potential for systemic, cell-type specific, antibody-mediated siRNA delivery...
  10. ncbi miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements
    Ashish Lal
    Immune Disease Institute, Children s Hospital Boston, Department of Pediatrics, Harvard Medical School, MA 02115, USA
    Mol Cell 35:610-25. 2009
    ..The E2F2 3'UTR lacks a predicted miR-24 recognition element. In fact, miR-24 regulates expression of E2F2, MYC, AURKB, CCNA2, CDC2, CDK4, and FEN1 by recognizing seedless but highly complementary sequences...
  11. ncbi miR-200 enhances mouse breast cancer cell colonization to form distant metastases
    Derek M Dykxhoorn
    Department of Pediatrics, Immune Disease Institute, Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 4:e7181. 2009
    ..Because some miRNAs are dysregulated in cancer and affect cellular transformation, tumor formation, and metastasis, we examined whether changes in miRNA expression might explain the differences in metastasis of these cells...
  12. ncbi Silencing viral infection
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
    PLoS Med 3:e242. 2006
  13. ncbi A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication
    Dipanjan Chowdhury
    Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA
    Mol Cell 31:33-46. 2008
    ..Therefore, gamma-H2AX elimination at DNA damage foci is required for DNA damage repair, but accomplishing this task involves distinct phosphatases with potentially overlapping roles...
  14. ncbi Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism
    Derek M Dykxhoorn
    CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 103:5953-8. 2006
    ....
  15. ncbi RNA interference and cancer: endogenous pathways and therapeutic approaches
    Derek M Dykxhoorn
    Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA
    Adv Exp Med Biol 615:299-329. 2008
    ..Possible strategies and obstacles to harnessing RNAi for cancer therapy will also be discussed...
  16. ncbi Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death
    Denis Martinvalet
    Immune Disease Institute and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
    Cell 133:681-92. 2008
    ..Target cells expressing a cleavage site mutant of NDUFS3 are resistant to GzmA-mediated cell death but remain sensitive to GzmB...
  17. ncbi siRNA-directed inhibition of HIV-1 infection
    Carl D Novina
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
    Nat Med 8:681-6. 2002
    ..siRNAs effectively inhibit pre- and/or post-integration infection events in the HIV-1 life cycle. Thus, siRNAs may have potential for therapeutic intervention in HIV-1 and other viral infections...
  18. ncbi Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
    Lee Adam Wheeler
    Immune Disease Institute and Program in Cellular and Molecular Medicine, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Invest 121:2401-12. 2011
    ..When applied intravaginally to humanized mice, CD4-AsiCs protected against HIV vaginal transmission. Thus, CD4-AsiCs could be used as the active ingredient of a microbicide to prevent HIV sexual transmission...
  19. ncbi Killing the messenger: short RNAs that silence gene expression
    Derek M Dykxhoorn
    Center for Cancer Research, Massachusetts Institute of Technology, 40 Ames Street, E17-529, Cambridge, Massachusetts 02139, USA
    Nat Rev Mol Cell Biol 4:457-67. 2003
    ..Much of the promise of RNA interference will depend on the recent advances in short-RNA-based silencing technologies...
  20. ncbi Genetic analysis of the subunit organization and function of the conserved oligomeric golgi (COG) complex: studies of COG5- and COG7-deficient mammalian cells
    Toshihiko Oka
    Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    J Biol Chem 280:32736-45. 2005
    ..Only one or two of the seven Cog1- or Cog2-dependent Golgi membrane proteins called GEARs are also sensitive to Cog5 or Cog7 deficiency, indicating that the COG subunits play distinctive roles in controlling Golgi structure and function...
  21. ncbi Lentivirus-delivered stable gene silencing by RNAi in primary cells
    Sheila A Stewart
    Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA
    RNA 9:493-501. 2003
    ....